A genetic risk result came back. What does it change, and who should I talk to?

What is ApoE4, and what does an ApoE 3/4 or 4/4 result mean?

ApoE4 is one version of the APOE gene, and carrying it raises the odds of late-onset Alzheimer's disease without deciding who develops it. The gene makes apolipoprotein E, a protein that moves cholesterol and other fats through the blood and brain. It comes in three common versions, e2, e3 and e4, and everyone inherits two copies. A 3/3 result, the most common pairing, is the usual reference. A 3/4 result means one copy of e4, and a 4/4 result means two.

ApoE4 is the strongest common genetic risk factor for late-onset Alzheimer's disease [PMID: 37930705]. In pooled studies of White participants, one copy carried about three times the odds of a 3/3 result, and two copies about fifteen times [PMID: 9343467]. The link is weaker in Black and Hispanic people, stronger in people of East Asian ancestry [PMID: 37930705], and fades after age 70 [PMID: 9343467].

In absolute terms the picture is calmer. One analysis put the risk of Alzheimer's disease by age 85 at about 23 percent for men and 30 percent for women with one copy, against 11 and 14 percent overall, and at 51 to 60 percent with two copies [PMID: 21556001]. Population-based cohorts give lower figures for two copies: about 30 to 40 percent of cognitively healthy people aged 60 to 75 developed mild cognitive impairment or dementia by their early eighties [PMID: 28323826]. Many carriers never develop dementia, and many people with Alzheimer's disease carry no e4.

How is ApoE4 tested?

ApoE4 is tested from a blood, saliva or cheek-swab sample, through a clinical laboratory on a clinician's order or through a consumer genetic report. What differs is what surrounds the result.

A clinical test usually comes with genetic counseling before and after: what the result can and cannot say, what it means for blood relatives, and whether the person wants to know at all. Predictive ApoE testing was discouraged for years [PMID: 19605829], and it remains a personal choice, not a routine screen. Consumer reports are another route to the same genotype, with counseling arranged separately: 23andMe, for example, describes its Genetic Health Risk reports as telling a person about genetic variants associated with increased risk for certain health conditions. A genotype says nothing about how the brain is working now, a separate question covered in what a cognitive test score or an Alzheimer's blood test means.

What is worth doing if a test shows the ApoE4 gene?

An ApoE4 result calls for no urgent action, and no treatment is given on the strength of the gene alone. What it changes is the value of looking after everything else that feeds dementia risk.

A Lancet Commission review ties a substantial share of dementia worldwide to modifiable factors, among them high blood pressure, hearing loss, diabetes, obesity, smoking, depression and physical inactivity, and notes that hearing aids appear to reduce the excess risk from hearing loss [PMID: 32738937]. ApoE connects to that list directly: LDL cholesterol rises stepwise from the e2 to the e4 versions of the gene [PMID: 17878422]. Sleep belongs on the working agenda too, and the cognitive decline guide covers each factor in depth.

For carriers the evidence is encouraging. In a two-year randomized trial of diet, exercise, cognitive training and vascular risk management, the cognitive benefit was evident in e4 carriers and did not differ significantly from that in non-carriers [PMID: 29356827].

What does a positive BRCA result mean, and what comes next?

A harmful variant in BRCA1 or BRCA2, genes that help repair damaged DNA, is associated with a higher risk of breast, ovarian, fallopian tube and peritoneal cancer [PMID: 31429903]. It is a result that can change care, so the first step is confirmation and the second is a genetic counselor.

Most consumer tests check three BRCA variants that are most common in people of Ashkenazi Jewish ancestry, a small share of the harmful variants known. In one large study that approach missed more than 90 percent of harmful BRCA variants in people without that ancestry [PMID: 37535880]. A negative consumer result does not rule a variant out, and a positive one is confirmed in a clinical laboratory before any decision is made.

A genetic counselor maps the family history, arranges the clinical test, explains what a confirmed variant means for relatives of both sexes, and lays out the options guidelines describe: more intensive screening, risk-reducing medication and risk-reducing surgery [PMID: 31429903]. Those decisions belong to the person, made with the counselor and the relevant specialists.

What about an MTHFR result?

For most people an MTHFR result is the least consequential finding on a genetic report. MTHFR is a gene for an enzyme that helps process folate, a B vitamin, and recycle homocysteine, an amino acid in the blood. Its common variants are widespread and lower the enzyme's activity modestly.

The American College of Medical Genetics and Genomics concluded that MTHFR variant testing has minimal clinical utility and should not be part of a routine evaluation for clotting risk. The meta-analyses it cites found no link between MTHFR status and venous blood clots, or between raised homocysteine and coronary heart disease [PMID: 23288205]. When the pathway is a genuine question, a physician measures it directly: homocysteine and the B vitamin levels it depends on. A variant alone does not establish a deficiency or explain fatigue or mood.

What does a physician do with a consumer genetic report?

A physician treats a consumer genetic report as a starting point: what it actually tested, whether it needs confirming, and what it would change.

• Family history first. Who was affected, by what, and at what age.
• What the test covered. A report on a few variants says nothing about the rest of a gene.
• Confirmation and counseling. Raw data run through third-party interpretation tools needs particular care: in one clinical laboratory's series, 40 percent of variants reported that way were false positives on confirmatory testing [PMID: 29565420].
• What can be measured now. Lipids, blood pressure, blood sugar, sleep, hearing and cognition.
• What would change the plan. Earlier or more intensive screening, a referral to genetics, oncology, cardiology or neurology, or no change at all.

When is support needed after a genetic result?

Most people absorb a risk result without lasting harm. In a randomized trial, adult children of people with Alzheimer's disease who learned their ApoE genotype with counseling showed no more anxiety, depression or distress over the following year than those not told, though people already distressed before testing were more likely to struggle afterwards [PMID: 19605829]. A result that causes significant distress, such as persistent anxiety, low mood or lost sleep, is a reason to seek support promptly from a physician, a genetic counselor or a mental health professional, and thoughts of self-harm are a reason to call or text 988 or go to the nearest emergency department.

Can a genetic report ordered without a physician be reviewed?

Yes. A report from a consumer kit or a testing service a person ordered on their own is reviewed as part of care. The full report helps more than the headline: the test name, the laboratory, the genes and variants covered, and whether any finding came from a raw data file. A written family history, with ages at diagnosis where known, is the other half.

The deeper picture

A genetic result is the one laboratory value that never changes, so everything useful about it lies in the interpretation. Most inherited risk is spread across many small-effect variants, and the polygenic scores that add them up are an emerging tool whose usefulness varies by condition and by ancestry. Genes set a starting point; blood pressure, lipids, glucose, sleep, hearing and fitness decide much of what follows. At Extend Medical a genetic report is read that way, with physician-level clinical rigor: against the family history, the current numbers and what would change the plan.